BETSY VAN HAAFTEN: Open Payments
NPI 1023609690 · JOHNSTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,286 in 53 payments from 11 companies in 2025. Trend: 2023 $428 · 2024 $628 · 2025 $1,286
Food & beverage: $1,286
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 4 | $432 |
| Janssen Biotech, Inc. | 10 | $274 |
| UCB, Inc. | 7 | $197 |
| ABBVIE INC. | 18 | $160 |
| Galderma Laboratories, L.P. | 3 | $74 |
| Organon LLC | 6 | $47 |
| Lilly USA, LLC | 1 | $30 |
| Arcutis Biotherapeutics, Inc. | 1 | $22 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $19 |
| PFIZER INC. | 1 | $17 |
Products named: Rhapsido, TREMFYA, Bimzelx, SKYRIZI, NEMLUVIO, RINVOQ, TALTZ, VTAMA.
Industry payments across IA — which companies pay providers there.
